Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

磁刺激 萧条(经济学) 随机对照试验 深部经颅磁刺激 医学 内科学 物理医学与康复 刺激 精神科 宏观经济学 经济
作者
John P. O’Reardon,H. Brent Solvason,Philip G. Janicak,Shirlene M. Sampson,Keith E. Isenberg,Ziad H. Nahas,William Maffitt McDonald,David Avery,Paul Bernard Fitzgerald,Colleen K A Loo,Mark A. Demitrack,Mark S. George,Harold A. Sackeïm
出处
期刊:Biological Psychiatry [Elsevier BV]
卷期号:62 (11): 1208-1216 被引量:2083
标识
DOI:10.1016/j.biopsych.2007.01.018
摘要

Background

We tested whether transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (DLPFC) is effective and safe in the acute treatment of major depression.

Methods

In a double-blind, multisite study, 301 medication-free patients with major depression who had not benefited from prior treatment were randomized to active (n = 155) or sham TMS (n = 146) conditions. Sessions were conducted five times per week with TMS at 10 pulses/sec, 120% of motor threshold, 3000 pulses/session, for 4–6 weeks. Primary outcome was the symptom score change as assessed at week 4 with the Montgomery–Asberg Depression Rating Scale (MADRS). Secondary outcomes included changes on the 17- and 24-item Hamilton Depression Rating Scale (HAMD) and response and remission rates with the MADRS and HAMD.

Results

Active TMS was significantly superior to sham TMS on the MADRS at week 4 (with a post hoc correction for inequality in symptom severity between groups at baseline), as well as on the HAMD17 and HAMD24 scales at weeks 4 and 6. Response rates were significantly higher with active TMS on all three scales at weeks 4 and 6. Remission rates were approximately twofold higher with active TMS at week 6 and significant on the MADRS and HAMD24 scales (but not the HAMD17 scale). Active TMS was well tolerated with a low dropout rate for adverse events (4.5%) that were generally mild and limited to transient scalp discomfort or pain.

Conclusions

Transcranial magnetic stimulation was effective in treating major depression with minimal side effects reported. It offers clinicians a novel alternative for the treatment of this disorder.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
还等雨落的应助被MG采纳,获得10
刚刚
刚刚
xLi发布了新的文献求助10
1秒前
无私代芹完成签到,获得积分10
1秒前
1秒前
三拾壹完成签到 ,获得积分10
2秒前
taipingyang发布了新的文献求助10
3秒前
3秒前
杨羽完成签到,获得积分10
4秒前
tom发布了新的文献求助10
4秒前
流浪文献完成签到,获得积分10
4秒前
4秒前
5秒前
大白菜完成签到,获得积分10
5秒前
6秒前
暮谷完成签到,获得积分20
7秒前
lshlsh完成签到 ,获得积分10
7秒前
简单的大哥完成签到,获得积分10
7秒前
pokexuejiao发布了新的文献求助30
7秒前
搜集达人的应助被隐形冰之采纳,获得30
7秒前
hanbulashiga发布了新的文献求助10
8秒前
yuzu发布了新的文献求助10
8秒前
nagaaa完成签到,获得积分10
8秒前
香蕉觅云的应助被长情的凌旋采纳,获得10
8秒前
猪大肠呵呵完成签到,获得积分10
8秒前
体贴苠的应助被Gu0F1采纳,获得10
8秒前
充电宝的应助被yanghuikai采纳,获得10
8秒前
文嚓茶完成签到,获得积分10
9秒前
余舟唱晚关注了科研通微信公众号
9秒前
MrLiu完成签到,获得积分10
10秒前
日晖下浅浅的微笑完成签到,获得积分20
10秒前
luermei完成签到,获得积分10
10秒前
10秒前
orixero的应助被川里九樱采纳,获得10
10秒前
小拉卡咪发布了新的文献求助10
10秒前
情怀的应助被yu采纳,获得10
11秒前
11秒前
多多发布了新的文献求助10
12秒前
无花果的应助被菲菲采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264